Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...
EMA committee recommends approval for AbbVie’s Maviret for the treatment of acute hepatitis C infection: North Chicago, Illinois Monday, May 25, 2026, 18:00 Hrs [IST] AbbVie, an ...
People could learn within 15 minutes whether they are infected with hepatitis C, thanks to a rapid test developed by Northwestern University. The test will allow doctors to diagnose infections during ...
The Indian Patent Office has refused to grant a patent to US pharmaceutical firm AbbVie on its Hepatitis C combination ...
MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for ...
WASHINGTON – It is possible to end the transmission of hepatitis B and C and prevent further sickness and deaths from the diseases, but time, considerable resources, and attention to various barriers ...
Oregon Health & Science University (OHSU) has been awarded $7.5 million in federal funding to increase treatment and ...
On Tuesday, Cherokee Nation Principal Chief Chuck Hoskin Jr. signed a proclamation designating May as Hepatitis C Awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results